Beta Bionics, Inc.

US$15.70As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BBNXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (23.88%)
Medical Devices
Beta (5Y) —
PE TTM —
TSR TTM (42.32%)
Mkt cap US$853.6M
ROIC (16.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
8.69%
(98.52%)
Sell 0|5|5|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.26
0.29
0.31
9.37%
10.73%
16.46%
29.86%
Revenue$M
42.52
44.30
46.02
46.64
5.69%
6.42%
12.03%
9.31%
Peers (US$853.6M)
Cap (US$)
PE
894.0M
13.12x
849.4M
30.65x
Capital
TTM
5Y
10Y
Leveragex
2.170
0.071
0.064
EBIT/Intx
2.602
0.468
0.486
Own earn%
53.00
14.03
17.12
Sh yield%
31.24
37.69
32.00
Owners
Insiders/Inst%
0.56
58.87
Short interest%
1.68
SBC / revenue%
3.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
−4